Milwaukee, WI, United States of America

Mark Adams

This inventor holds 1 USPTO granted patent. Top assignee: Baxter Travenol Laboratories, Inc.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Adams. Retrieved from https://idiyas.com/inventor/mark-adams-2mkt517f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Adams - Innovator in Drug Administration Methods

Introduction

Mark Adams is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of drug administration, particularly through his innovative methods that enhance the delivery of lipophilic drugs.

Latest Patents

Adams holds a patent for a "Method for drug administration." This invention focuses on a unique approach where a lipophilic drug is solubilized by a food, such as chocolate, and mixed with an oil-based carrier. This method ensures that the lipid-soluble drug is effectively conveyed to the gastrointestinal tract. The use of easily digestible food allows for the intended absorption of the drug, minimizing day-to-day variations in dosage.

Career Highlights

Mark Adams is currently employed at Baxter Travenol Laboratories, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug administration methods has positioned him as a valuable asset to his team.

Collaborations

Some of his coworkers include Rahim Hamid and Gerado Caballero, who contribute to the collaborative environment at Baxter Travenol Laboratories, Inc.

Conclusion

Mark Adams is a pioneering inventor whose work in drug administration methods has the potential to improve patient outcomes significantly. His innovative approach to solubilizing drugs with food represents a meaningful advancement in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…